Author details

Full Name

Rivka R Colen

Affiliation

ORCID

Career Start Year

2004

Papers

122

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37381160	Neuroimaging findings in 4342 hospitalized COVID-19 subjects: A multicenter report from the United States and Europe.	J Neuroimaging	2023
37881491	TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype <i>in vitro</i>.	Front Oncol	2023
36510640	Changes in outcomes and factors associated with survival in melanoma patients with brain metastases.	Neuro Oncol	2023
36702828	Author Correction: Federated learning enables big data for rare cancer boundary detection.	Nat Commun	2023
34649914	Evolving Role and Translation of Radiomics and Radiogenomics in Adult and Pediatric Neuro-Oncology.		2022
36239836	Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients.	Journal of Neuro-Oncology	2022
35650597	Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients withÂ non-small cell lung cancer.	J Exp Clin Cancer Res	2022
35760886	A general skull stripping of multiparametric brain MRIs using 3D convolutional neural network.	Scientific Reports	2022
35879397	Author Correction: A general skull stripping of multiparametric brain MRIs using 3D convolutional neural network.	Scientific Reports	2022
35414643	A weakly supervised deep learning-based method for glioma subtype classification using WSI and mpMRIs.	Scientific Reports	2022
35663832	Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study.	J Immunother Precis Oncol	2022
36998700	QU-BraTS: MICCAI BraTS 2020 Challenge on Quantifying Uncertainty in Brain Tumor Segmentation - Analysis of Ranking Scores and Benchmarking Results.	J Mach Learn Biomed Imaging	2022
36470898	Federated learning enables big data for rare cancer boundary detection.	Nat Commun	2022
34731355	Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a singleâ¿¿center, multiâ¿¿arm phase Ib study.	Invest New Drugs	2022
34705134	Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.	Invest New Drugs	2022
34530385	Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma.	EBioMedicine	2021
35663531	Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy Specimens.	J Immunother Precis Oncol	2021
33747933	Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer.	Frontiers in Oncology	2021
33849924	Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.	J Immunother Cancer	2021
34315823	Author response to Cunha <i>et al</i>.	J Immunother Cancer	2021
34972979	Cancer Imaging in Immunotherapy.	Advances in Experimental Medicine and Biology	2021
34965890	Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors.	Exp Hematol Oncol	2021
34377884	Clinical Outcomes in Non-Small-Cell Lung Cancer Patients Treated With EGFR-Tyrosine Kinase Inhibitors and Other Targeted Therapies Based on Tumor Versus Plasma Genomic Profiling.	JCO Precis Oncol	2021
33426529	A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogram.	Neurooncol Adv	2020
32188704	Phase 2 study of pembrolizumab in patients with advanced rare cancers.	J Immunother Cancer	2020
32179095	Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases.	Magnetic Resonance Imaging	2020
32301025	Cancer Imaging in Immunotherapy.	Advances in Experimental Medicine and Biology	2020
31665446	Magnetic Resonance-Based Radiomic Analysis of Radiofrequency Lesion Predicts Outcomes After Percutaneous Cordotomy: A Feasibility Study.	Operative Neurosurgery	2020
32391274	Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach.	Frontiers in Oncology	2020
32152626	Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma.	Neuro-Oncology	2020
32152622	AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium.	Neuro Oncol	2020
31755915	Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages.	Neuro Oncol	2020
32653026	The role of resting-state functional MRI for clinical preoperative language mapping.	Cancer Imaging	2020
33227089	Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation.	Oncotarget	2020
32724046	Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data.	Sci Rep	2020
31320621	Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma.	Nat Commun	2019
31597366	Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome.	Cancers	2019
31615562	Neurosurgical applications of MRI guided laser interstitial thermal therapy (LITT).	Cancer Imaging	2019
30888569	Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data.	Cancer Causes Control	2019
29848016	The vast potential and bright future of neuroimaging.	Br J Radiol	2018
30148217	A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter?	Clin Transl Radiat Oncol	2018
30054278	A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.	Clin Cancer Res	2018
29619649	Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome.	J Neurooncol	2018
29660006	Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.	Neuro Oncol	2018
29075985	Radiomics to predict immunotherapy-induced pneumonitis: proof of concept.	Invest New Drugs	2018
29328002	Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.	J Neurosurg	2018
29159766	Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience.	Invest New Drugs	2018
29799635	Comparison of functional localization accuracy with different co-registration strategies in presurgical fMRI for brain tumor patients.		2018
28079714	Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images.	Topics in Magnetic Resonance Imaging	2017
28917284	Neurosurgical Applications of High-Intensity Focused Ultrasound with Magnetic Resonance Thermometry.	Neurosurgery Clinics of North America	2017